التفاصيل البيبلوغرافية
| العنوان: |
Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma. |
| المؤلفون: |
Sanfilippo, K. M., Gage, B., Luo, S., Weilbaecher, K., Tomasson, M., Vij, R., Colditz, G., Carson, K. |
| المصدر: |
Leukemia & Lymphoma; Mar2015, Vol. 56 Issue 3, p615-621, 7p |
| مصطلحات موضوعية: |
ZOLEDRONIC acid, DISODIUM pamidronate, MULTIPLE myeloma treatment, DRUG side effects, AMERICAN veterans |
| مستخلص: |
Zoledronic acid and pamidronate are the two bisphosphonates approved in the United States to reduce multiple myeloma skeletal complications. Little prior evidence exists comparing survival outcomes between the two. We evaluated the incidence of skeletal-related events and overall survival in patients with myeloma treated with zoledronic acid versus pamidronate using a cohort of 1018 United States veterans. At a median follow-up of 26.9 months, patients receiving zoledronic acid had a 22% reduction in risk of death compared to pamidronate (hazard ratio 0.78; 95% confidence interval, 0.67-0.92). The benefit persisted after controlling for potential confounders. Adjusted Cox modeling with inverse probability weighting and propensity score matching supported these findings. Zoledronic acid was also associated with a 25% decrease in skeletal-related events. Zoledronic acid is associated with increased overall survival and decreased skeletal-related events compared to pamidronate in patients with multiple myeloma and should become the preferred bisphosphonate. [ABSTRACT FROM AUTHOR] |
|
Copyright of Leukemia & Lymphoma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
